Advertisement

Health


Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Melbourne-based probiotics company Biome Australia (ASX: BIO) has s...

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

Queensland-based biotech startup Gutgutgoose has been accepted into...

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) ha...

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo Healthcare & Wellness REIT (ASX: HCW) has secured a ne...

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

Digital health accelerator ANDHealth has awarded up to $9 million i...

Advertisement
Advertisement
Advertisement
IVF is big business. But when patients become customers, what does this mean for their care?

IVF is big business. But when patients become customers, what does this mean for their care?

Monash IVF CEO Michael Knaap has resigned after one of the company&...

Fertility group Monash IVF rocked by a second embryo mix-up, pushing shares 26pc lower

Fertility group Monash IVF rocked by a second embryo mix-up, pushing shares 26pc lower

Melbourne-based fertility services provider Monash IVF Group (ASX: ...

AI-backed medical scribe Lyrebird Health raises $12m as fast-growing startup eyes UK and Middle East

AI-backed medical scribe Lyrebird Health raises $12m as fast-growing startup eyes UK and Middle East

Melbourne-based Lyrebird Health, a medical scribe that generates cl...

Tetratherix launches $25m IPO with plans for bone regeneration biotech roll-out in 2026

Tetratherix launches $25m IPO with plans for bone regeneration biotech roll-out in 2026

A homegrown biotechnology story that has been 15 years in the makin...

Sepsis fatalities reduced as Microbio, ARM Hub combine AI with pathogen detection biotech

Sepsis fatalities reduced as Microbio, ARM Hub combine AI with pathogen detection biotech

Brisbane-based startup Microbio, which developed a rapid diagnostic...

Healthscope hospital landlord agrees to partial rent deferral deal, receives expressions of interest

Healthscope hospital landlord agrees to partial rent deferral deal, receives expressions of interest

The landlord that owns 11 of Healthscope's 37 private hospitals...

Healthscope in receivership but $100m lifeline will keep hospitals open amid sale process

Healthscope in receivership but $100m lifeline will keep hospitals open amid sale process

The financial crisis hounding Australian private hospital group Hea...

Pancreatic cancer medtech OncoSil raising $8.7m as it edges closer to cashflow breakeven

Pancreatic cancer medtech OncoSil raising $8.7m as it edges closer to cashflow breakeven

Pancreatic cancer treatment device company OncoSil Medical (ASX: OS...

PolyNovo’s technology proves critical in Beta Cell’s breakthrough transplant treatment for diabetics

PolyNovo’s technology proves critical in Beta Cell’s breakthrough transplant treatment for diabetics

Shares in Melbourne-based biotech PolyNovo (ASX: PNV) surged more t...

Althea Group’s focus turns to THC drinks after selling pharmaceutical assets to Tasmanian Botanics

Althea Group’s focus turns to THC drinks after selling pharmaceutical assets to Tasmanian Botanics

Althea Group Holdings (ASX: AGH) has sold its pharmaceutical assets...

Telix declares its resilience amid tariff turmoil as Q1 revenue surges to $291m

Telix declares its resilience amid tariff turmoil as Q1 revenue surges to $291m

Melbourne-based Telix Pharmaceuticals’ (ASX: TLX) expansion o...

Dental Boutique taps into “hub for beauty” community with launch of purpose-built Gold Coast clinic

Dental Boutique taps into “hub for beauty” community with launch of purpose-built Gold Coast clinic

Fast-growing cosmetic dentistry group Dental Boutique is building u...

Eye health biotech Opthea to cull 65pc of workforce to conserve cash after failed late-stage trial

Eye health biotech Opthea to cull 65pc of workforce to conserve cash after failed late-stage trial

In the wake of failed late-stage clinical trials last month for its...

CSIRO’s ON accelerator selects 11 groundbreaking startups from clean ammonia to knee surgery tech

CSIRO’s ON accelerator selects 11 groundbreaking startups from clean ammonia to knee surgery tech

From pioneering clean ammonia production to developing devices that...

Trump's impending "major" tariff announcement wipes $6.1 billion from leading ASX pharma companies

Trump's impending "major" tariff announcement wipes $6.1 billion from leading ASX pharma companies

The three largest pharmaceutical companies listed on the Australian...

Advertisement

Partner Content

Introduction: the natural desire to time marketsWhen investors cons...
IntroductionFor decades, term deposits have been a cornerstone of c...
Introduction: A Simple Line With Complex SignalsIn financial market...
Equi Consultancy Partners joined regional leaders at the WEConnect ...
If you run a business website, it’s easy to focus on what custome...
For many Australians, the journey with money begins in a very pract...
Introduction: How Investment Priorities Quietly Change Over TimeInv...
Advertisement